The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
A cytokine-mediated link between innate immunity, inflammation, and cancer
Open accessAbstract
It has been established that cancer can be promoted and/or exacerbated by inflammation and infections. Indeed, chronic inflammation orchestrates a tumor-supporting microenvironment that is an indispensable participant in the neoplastic process. The mechanisms that link infection, innate immunity, inflammation, and cancer are being unraveled at a fast pace. Important components in this linkage are the cytokines produced by activated innate immune cells that stimulate tumor growth and progression. In addition, soluble mediators produced by cancer cells recruit and activate inflammatory cells, which further stimulate tumor progression. However, inflammatory cells also produce cytokines that can limit tumor growth. Here we provide an overview of the current understanding of the role of inflammation-induced cytokines in tumor initiation, promotion, and progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“After chronic stress breaks this balance through a long-term pro-inflammatory response, these cells and cytokines can act on all stages of tumor development, including initiation, promotion, malignant transformation, invasion, and metastasis through mutation, epigenetic modification, and regulation of the tumor microenvironment [(50, 51); Figure 3].”
From Chronic Stress Promotes Cancer Development (2020) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 12,401
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,498
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
Research works printed but not linked: 12
- Shacter, 2002, Oncology., 16, 217
- Sehouli, 2002, Anticancer Res., 22, 3421
- Kitakata, 2002, Cancer Res., 62, 6682
- Gado, 2001, Haematologica., 86, 227
- Tartour, 1999, Cancer Res., 59, 3698
- Trinchieri, 2003, Nat. Rev., 3, 133
- Erdman, 2003, Cancer Res., 63, 6042
- Kohno, 2003, Cancer Res., 63, 5091
- Alas, 2001, Clin. Cancer Res., 7, 709
- Lech-Maranda, 2006, Eur. Cytokine Netw., 17, 60
- Parsons, 1995, Cancer Res., 55, 5548
- Engle, 2002, Cancer Res., 62, 6362
Cited by
Sorted by citations
Items 201–300 of 999
Inflammation, DNA methylation and colitis-associated cancer
Hartnett, L., & Egan, L. J. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs006 · Cited by 165
Plasma YKL-40: A Potential New Cancer Biomarker?
Johansen, J. S., Schultz, N. A., & Jensen, B. V. (2009) · Future Oncology · doi:10.2217/fon.09.66 · Cited by 160
miRNA regulation of cytokine genes
Asirvatham, A. J., Magner, W. J., & Tomasi, T. B. (2009) · Cytokine · doi:10.1016/j.cyto.2008.11.010 · Cited by 168
NF-κB as a central regulator of macrophage function in tumors
Biswas, S. K., & Lewis, C. E. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310153 · Cited by 166
Lupeol: Connotations for chemoprevention
Chaturvedi, P. K., Bhui, K., & Shukla, Y. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.01.047 · Cited by 161
The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation
Ahmed, N., Zeng, M., Sinha, I., Polin, L., Wei, W., Rathinam, C., Flavell, R. A., Massoumi, R., & Venuprasad, K. (2011) · Nature Immunology · doi:10.1038/ni.2157 · Cited by 160
The key role of extracellular vesicles in the metastatic process
Zhao, H., Achreja, A., Iessi, E., Logozzi, M., Mizzoni, D., Raimo, R. D., Nagrath, D., & Fais, S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.11.005 · Cited by 164
Transforming Growth Factor-Beta: Recent Advances on Its Role in Immune Tolerance
Mantel, P., & Schmidt‐Weber, C. B. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-869-0_21 · Cited by 157
Hyam, S. R., Lee, I., Gu, W., Kim, K., Jeong, J.-J., Jang, S., Han, M. J., & Kim, D. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.014 · Cited by 155
Ndlovu, M. N., Lint, C. M. V., Wesemael, K. V., Callebert, P., Chalbos, D., Haegeman, G., & Berghe, W. V. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01657-08 · Cited by 153
Colitis-Associated Colorectal Cancer Driven by T-bet Deficiency in Dendritic Cells
Garrett, W. S., Punit, S., Gallini, C. A., Michaud, M., Zhang, D., Sigrist, K. S., Lord, G. M., Glickman, J. N., & Glimcher, L. H. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.07.015 · Cited by 155
Anti-Inflammatory Activity of Sulfur-Containing Compounds from Garlic
Lee, D. Y., Li, H., Lim, H. J., Lee, H. J., Jeon, R., & Ryu, J. (2012) · Journal of Medicinal Food · doi:10.1089/jmf.2012.2275 · Cited by 155
Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancer
Shi, C., Yang, Y. P., Xia, Y., Okugawa, Y., Yang, J., Liang, Y., Chen, H., Zhang, P., Wang, F., Han, H., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308455 · Cited by 159
Sungur, T., Aslım, B., Karaaslan, Ç., & Aktaş, B. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.05.013 · Cited by 159
Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment
Menon, H., Ramapriyan, R., Cushman, T. R., Verma, V., Kim, H. H., Schoenhals, J. E., Atalar, S. C., Selek, U., Chun, S. G., Chang, J. Y., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00193 · Cited by 160
The Gastrointestinal Tumor Microenvironment
Quante, M., Varga, J., Wang, T. C., & Greten, F. R. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.03.052 · Cited by 154
Chemokine Function in Periodontal Disease and Oral Cavity Cancer
Sahingur, S. E., & Yeudall, W. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00214 · Cited by 157
Dendritic Cell-Based Vaccines: Barriers and Opportunities
Cintolo, J. A., Datta, J., Mathew, S., & Czerniecki, B. J. (2012) · Future Oncology · doi:10.2217/fon.12.125 · Cited by 157
Colorectal cancer immunotherapy-Recent progress and future directions
Zhao, W., Jin, L., Chen, P., Li, D., Gao, W., & Dong, G. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215816 · Cited by 159
Evidence and Mechanisms of Fat Depletion in Cancer
Ebadi, M., & Mazurak, V. C. (2014) · Nutrients · doi:10.3390/nu6115280 · Cited by 152
Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors
Henry, C. J., Casás-Selves, M., Kim, J., Zaberezhnyy, V., Aghili, L., Daniel, A. E., Jimenez, L., Azam, T., McNamee, E. N., Clambey, E. T., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83024 · Cited by 148
Jin, G., Kawsar, H. I., Hirsch, S. A., Zeng, C., Jia, X., Feng, Z., Ghosh, S. K., Zheng, Q. Y., Zhou, A., McIntyre, T. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010993 · Cited by 152
A Critical Role for Macrophages in Promotion of Urethane-Induced Lung Carcinogenesis
Zaynagetdinov, R., Sherrill, T. P., Polosukhin, V. V., Han, W., Ausborn, J. A., McLoed, A. G., McMahon, F. B., Gleaves, L. A., Degryse, A. L., Stathopoulos, G. T., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100558 · Cited by 147
Aubertin, K., Silva, A., Luciani, N., Espinosa, A., Djemat, A., Charue, D., Gallet, F., Blanc‐Brude, O., & Wilhelm, C. (2016) · Scientific Reports · doi:10.1038/srep35376 · Cited by 144
Diabetes and cancer: Pathophysiological fundamentals of a ‘dangerous affair’
Cignarelli, A., Genchi, V. A., Caruso, I., Natalicchio, A., Perrini, S., Laviola, L., & Giorgino, F. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.002 · Cited by 156
Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies
Crawford, Y., & Ferrara, N. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.09.004 · Cited by 144
The NF-κB/AKT-dependent Induction of Wnt Signaling in Colon Cancer Cells by Macrophages and IL-1β
Kaler, P., Godasi, B. N., Augenlicht, L. H., & Klampfer, L. (2009) · Cancer Microenvironment · doi:10.1007/s12307-009-0030-y · Cited by 147
Cytokine expression and signaling in drug-induced cellular senescence
Novakova, Z., Hubackova, S., Kosar, M., Janderova-Rossmeislova, L., Dobrovolna, J., Vasicova, P., Vancurova, M., Horejsi, Z., Hozak, P., Bartek, J., et al. (2010) · Oncogene · doi:10.1038/onc.2009.318 · Cited by 127
Mechanisms Linking Excess Adiposity and Carcinogenesis Promotion
Pérez-Hernández, A. I., Catalán, V., Gómez‐Ambrosi, J., RodrÃguez, A., & Frühbeck, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00065 · Cited by 148
Dumitru, C. A., Gholaman, H., Trellakis, S., Bruderek, K., Dominas, N., Gu, X., Bánkfalvi, Á., Whiteside, T. L., Lang, S., & Brandau, S. (2011) · International Journal of Cancer · doi:10.1002/ijc.25991 · Cited by 142
Canine Subcutaneous Mast Cell Tumor
Thompson, J. J., Pearl, D. L., Yager, J. A., Best, S. J., Coomber, B. L., & Foster, R. A. (2010) · Veterinary Pathology · doi:10.1177/0300985810387446 · Cited by 140
Endo, Y., Marusawa, H., Kou, T., Nakase, H., Fujii, S., Fujimori, T., Kinoshita, K., Honjo, T., & Chiba, T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.091 · Cited by 148
Is complement good or bad for cancer patients? A new perspective on an old dilemma
Markiewski, M. M., & Lambris, J. D. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.04.002 · Cited by 139
Lederle, W., Depner, S., Schnur, S., Obermueller, E., Catone, N., Just, A., Fusenig, N. E., & Mueller, M. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25621 · Cited by 140
Hayashi, D., Tamura, A., Tanaka, H., Yamazaki, Y., Watanabe, S., Suzuki, K., Suzuki, K. T., Sentani, K., Yasui, W., Rakugi, H., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.10.040 · Cited by 139
Silymarin impacts on immune system as an immunomodulator: One key for many locks
Esmaeil, N., Balouchi-Anaraki, S., Gharagozloo, M., & Moayedi, B. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.06.030 · Cited by 139
Genetic architecture of mouse skin inflammation and tumour susceptibility
Quigley, D. A., To, M. D., Pérez‐Losada, J., Pelorosso, F. G., Mao, J., Nagase, H., Ginzinger, D. G., & Balmain, A. (2009) · Nature · doi:10.1038/nature07683 · Cited by 135
Context-dependent functions of pattern recognition receptors in cancer
Man, S. M., & Jenkins, B. J. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00462-5 · Cited by 143
Overview of anti-inflammatory diets and their promising effects on non-communicable diseases
Yu, X., Pu, H., & Voss, M. (2024) · British Journal of Nutrition · doi:10.1017/s0007114524001405 · Cited by 134
Plant Sterols as Anticancer Nutrients: Evidence for Their Role in Breast Cancer
Grattan, B. J. (2013) · Nutrients · doi:10.3390/nu5020359 · Cited by 135
Inflammation, ageing and cancer
Vasto, S., Carruba, G., Lio, D., Colonna‐Romano, G., Bona, D. D., Candore, G., & Caruso, C. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.06.003 · Cited by 134
Musolino, C., Allegra, A., Innao, V., Allegra, A. G., Pioggia, G., & Gangemi, S. (2017) · Mediators of Inflammation · doi:10.1155/2017/1852517 · Cited by 168
The Dynamics of Signaling as a Pharmacological Target
Behar, M., Barken, D. M., Werner, S. L., & Hoffmann, A. (2013) · Cell · doi:10.1016/j.cell.2013.09.018 · Cited by 132
Harnessing the immune system to treat cancer
Bhardwaj, N. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32136 · Cited by 133
Wang, Z., Jin, H., Xu, R., Mei, Q., & Fan, D. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.10.078 · Cited by 131
Danckwardt, S., Hentze, M. W., & Kulozik, A. E. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1074-5 · Cited by 137
Mechanisms of bone metastases of breast cancer
Suva, L. J., Griffin, R. J., & Makhoul, I. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0012 · Cited by 131
Matsumoto, M., Tatematsu, M., Nishikawa, F., Azuma, M., Ishii, N., Morii-Sakai, A., Shime, H., & Seya, T. (2015) · Nature Communications · doi:10.1038/ncomms7280 · Cited by 130
The contribution of tumour-derived exosomes to the hallmarks of cancer
Meehan, K. L., & Vella, L. J. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1092496 · Cited by 134
Yin, Y., Zhou, Z., Liu, W., Chang, Q., Sun, G., & Dai, Y. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.01.001 · Cited by 131
Contribution of the immune system to bystander and non-targeted effects of ionizing radiation
Rödel, F., Frey, B., Multhoff, G., & Gaipl, U. S. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.015 · Cited by 129
Zhou, J., Ong, C. N., Hur, G. M., & Shen, H. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.12.014 · Cited by 128
Is Previous Respiratory Disease a Risk Factor for Lung Cancer?
Denholm, R., Schüz, J., Straíf, K., Stücker, I., Jöckel, K., Brenner, D. R., Matteis, S. D., Boffetta, P., Guida, F., Brüske, I., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0338oc · Cited by 127
Tanaka, R., Okiyama, N., Okune, M., Ishitsuka, Y., Watanabe, R., Furuta, J., Ohtsuka, M., Otsuka, A., Maruyama, H., Fujisawa, Y., et al. (2016) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2016.12.019 · Cited by 127
Inflammation: A key process in skin tumorigenesis (Review)
Neagu, M. T., Constantin, C., Căruntu, C., Dumitru, C., Surcel, M., & Zurac, S. (2018) · Oncology Letters · doi:10.3892/ol.2018.9735 · Cited by 129
Molecular and Cellular Mechanisms of Propolis and Its Polyphenolic Compounds against Cancer
Oršolić, N., & Jembrek, M. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810479 · Cited by 137
IL-1 in Colon Inflammation, Colon Carcinogenesis and Invasiveness of Colon Cancer
Voronov, E., & Apte, R. N. (2015) · Cancer Microenvironment · doi:10.1007/s12307-015-0177-7 · Cited by 128
Induced and natural regulatory T cells in human cancer
Whiteside, T. L., Schuler, P. J., & Schilling, B. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.707184 · Cited by 132
Alteration in Taste Perception in Cancer: Causes and Strategies of Treatment
Murtaza, B., Hichami, A., Khan, A. S., Ghiringhelli, F., & Khan, N. A. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00134 · Cited by 133
Ahechu, P., Zozaya, G., Martí, P., Hernández-Lizoáin, J. L., Baixauli, J., Unamuno, X., Frühbeck, G., & Catalán, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02918 · Cited by 131
Joh, E., Gu, W., & Kim, D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.04.020 · Cited by 125
Nanoparticles for tumor immunotherapy
Zang, X., Zhao, X., Hu, H., Qiao, M., Deng, Y., & Chen, D. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.03.013 · Cited by 127
Mazar, A. P. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4863 · Cited by 121
Mitochondrial dysfunction in cancer
Księżakowska‐Łakoma, K., Żyła, M. M., & Wilczyński, J. R. (2014) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2014.42717 · Cited by 120
Exosomes and their role in the micro-/macro-environment: a comprehensive review
Naureen, J., & Mukhopadhyay, D. (2017) · Journal of Biomedical Research · doi:10.7555/jbr.30.20150162 · Cited by 122
ROS: A “booster” for chronic inflammation and tumor metastasis
Chen, A., Huang, H., Fang, S., & Hang, Q. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189175 · Cited by 127
Protective effect of tetrahydrocoptisine against ethanol-induced gastric ulcer in mice
Li, W., Huang, H., Niu, X., Fan, T., Mu, Q., & Li, H. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.05.035 · Cited by 122
Protective Role of Dietary Berries in Cancer
Kristo, A. S., Klimis‐Zacas, D. J., & Sikalidis, A. K. (2016) · Antioxidants · doi:10.3390/antiox5040037 · Cited by 120
p53 and the Carcinogenicity of Chronic InflammationPreprint
Gudkov, A. V., & Komarova, E. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026161 · Cited by 126
Mechanisms linking pathogens-associated inflammation and cancer
Porta, C., Riboldi, E., & Sica, A. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.10.012 · Cited by 119
Schuler, P. J., Harasymczuk, M., Schilling, B., Saze, Z., Strauss, L., Lang, S., Johnson, J. T., & Whiteside, T. L. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0900 · Cited by 119
PKB/Akt-dependent regulation of inflammation in cancer
Tang, F., Wang, Y., Hemmings, B. A., Rüegg, C., & Xue, G. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.04.018 · Cited by 120
Pal, S., Bhattacharjee, A., Ali, A., Mandal, N. C., Mandal, S. C., & Pal, M. (2014) · Journal of Inflammation · doi:10.1186/1476-9255-11-23 · Cited by 119
PPARs Mediate Lipid Signaling in Inflammation and Cancer
Michalik, L., & Wahli, W. (2008) · PPAR Research · doi:10.1155/2008/134059 · Cited by 119
Aldubayan, M. A., Elgharabawy, R. M., Ahmed, A. S., & Tousson, E. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5162687 · Cited by 116
Peng, Q., Liu, H., Shi, S., & Li, M. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.03.023 · Cited by 116
Malignancy as a comorbidity in rheumatic diseases
Turesson, C., & Matteson, E. L. (2012) · Lara D. Veeken · doi:10.1093/rheumatology/kes189 · Cited by 115
Dysfunction of the Cochlea Contributing to Hearing Loss in Acoustic Neuromas
Röösli, C., Linthicum, F. H., Cüreoğlu, S., & Merchant, S. N. (2012) · Otology & Neurotology · doi:10.1097/mao.0b013e318248ee02 · Cited by 115
Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer
Lundgren, S., Berntsson, J., Nodin, B., Micke, P., & Jirström, K. (2016) · Journal of Ovarian Research · doi:10.1186/s13048-016-0232-0 · Cited by 118
The Process and Regulatory Components of Inflammation in Brain Oncogenesis
Mostofa, A., Punganuru, S. R., Madala, H. R., Al-Obaide, M., & Srivenugopal, K. S. (2017) · Biomolecules · doi:10.3390/biom7020034 · Cited by 121
Thymoquinone as a Potential Adjuvant Therapy for Cancer Treatment: Evidence from Preclinical Studies
Mostofa, A., Hossain, M. K., Basak, D., & Sayeed, M. S. B. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00295 · Cited by 121
The p38 MAPK stress pathway as a tumor suppressor or more?
Loesch, M. (2008) · Frontiers in bioscience · doi:10.2741/2951 · Cited by 115
The Role of Inflammation in Head and Neck Cancer
Bonomi, M. R., Patsias, A., Posner, M. R., & Sikora, A. G. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-0348-0837-8_5 · Cited by 114
Zinc and Cancer: Implications for LIV-1 in Breast Cancer
Grattan, B. J., & Freake, H. C. (2012) · Nutrients · doi:10.3390/nu4070648 · Cited by 120
Origin of carcinoma associated fibroblasts
Haviv, I., Polyák, K., Qiu, W., Hu, M., & Campbell, I. (2009) · Cell Cycle · doi:10.4161/cc.8.4.7669 · Cited by 118
Tumor microenvironment is multifaceted
Sautès‐Fridman, C., Cherfils‐Vicini, J., Damotte, D., Fisson, S., Fridman, W. H., Cremer, I., & Dieu‐Nosjean, M. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9279-y · Cited by 118
Prevalence and risk factors for mast cell tumours in dogs in England
Shoop-Worrall, S. J. W., Marlow, S., Church, D. B., English, K., McGreevy, P. D., Stell, A. J., Thomson, P. C., O'Neill, D. G., & Brodbelt, D. C. (2015) · Canine Genetics and Epidemiology · doi:10.1186/2052-6687-2-1 · Cited by 113
Wounding mobilizes hair follicle stem cells to form tumors
Wong, S. Y., & Reiter, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013098108 · Cited by 113
Rivera‐Cruz, C. M., Shearer, J. J., Neto, M. F., & Figueiredo, M. L. (2017) · Stem Cells International · doi:10.1155/2017/4015039 · Cited by 117
Khan, A. Q., Khan, R., Qamar, W., Lateef, A., Rehman, M. U., Tahir, M., Ali, F., Hamiza, O. O., Hasan, S. K., & Sultana, S. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.01.006 · Cited by 112
Cytokine regulation networks in the cancer microenvironment
Sheu, B. (2008) · Frontiers in bioscience · doi:10.2741/3152 · Cited by 116
Darding, M., & Meier, P. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.163 · Cited by 118
Zhao, Z., Zhao, X., Lu, J., Xue, J., Liu, P., & Mao, H. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4678-8 · Cited by 112
Flavonoids Regulate Inflammation and Oxidative Stress in Cancer
Li, G., Ding, K., Qiao, Y., Zhang, L., Zheng, L., Pan, T., & Zhang, L. (2020) · Molecules · doi:10.3390/molecules25235628 · Cited by 112
Li, R., Zhou, Y., Zhang, S., Li, J., Zheng, Y., & Fan, X. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174660 · Cited by 115
Dual delivery of biological therapeutics for multimodal and synergistic cancer therapies
Jang, B., Kwon, H., Katila, P., Lee, S. J., & Lee, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.023 · Cited by 111
Roles of NF-κB Signaling in the Regulation of miRNAs Impacting on Inflammation in Cancer
Markopoulos, G. S., Roupakia, E., Tokamani, M., Alabasi, G., Sandaltzopoulos, R., Marcu, K. B., & Kolettas, E. (2018) · Biomedicines · doi:10.3390/biomedicines6020040 · Cited by 116
Tumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective
Chen, W., Jiang, J., Xia, W., & Huang, J. (2017) · Journal of Immunology Research · doi:10.1155/2017/1073947 · Cited by 108
Brighenti, E., Calabrese, C., Liguori, G., Giannone, F. A., Treré, D., Montanaro, L., & Derenzini, M. (2014) · Oncogene · doi:10.1038/onc.2014.1 · Cited by 111
Lundin, J. I., & Checkoway, H. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0800439 · Cited by 108
Metadata
- Authors
- Lin, W.-W., & Karin, M.
- Affiliations
- National Taiwan University (TW)
- University of California San Diego (US)
- Corresponding author
- Karin, Michael
- Venue
- Journal of Clinical Investigation
- Published
- 2007-05-01
- Volume
- 117
- Issue
- 5
- Pages
- 1175-1183
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1857251
- OpenAlex
- W2133439754
- Cited by
- 1,940
- References
- 128
- Citations by year
- 2026: 18 · 2025: 39 · 2024: 60 · 2023: 92 · 2022: 93 · 2021: 117 · 2020: 117 · 2019: 102 · 2018: 93 · 2017: 123 · 2016: 104 · 2015: 127 · 2014: 134 · 2013: 130 · 2012: 124
- FWCI
- 8.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- cytokines, innate immunity, inflammation, cancer, chronic inflammation, tumor microenvironment, tumor promotion, tumor progression, infection and cancer, tumor initiation, inflammatory cells
- MeSH terms
- Animals, Humans, Immunity, Innate, Inflammation, Neoplasms, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review